Edition:
India

Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

0.92USD
10:57pm IST
Change (% chg)

$0.00 (+0.55%)
Prev Close
$0.91
Open
$0.90
Day's High
$0.94
Day's Low
$0.90
Volume
43,535
Avg. Vol
61,110
52-wk High
$1.80
52-wk Low
$0.43

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 1 0.09 0.09 0.09 --
Quarter Ending Dec-19 1 0.09 0.09 0.09 --
Year Ending Mar-19 3 0.00 0.00 0.00 3.24
Year Ending Mar-20 2 0.64 1.28 0.00 0.00
Earnings (per share)
Quarter Ending Sep-19 1 -0.07 -0.07 -0.07 --
Quarter Ending Dec-19 1 -0.06 -0.06 -0.06 --
Year Ending Mar-19 2 -0.69 -0.54 -0.84 -0.69
Year Ending Mar-20 2 -0.21 -0.17 -0.25 -0.71
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.89 36.81
P/E High - Last 5 Yrs. -- 50.39 57.83
P/E Low - Last 5 Yrs. -- 27.47 28.52
Beta -- 0.96 0.95
Price to Sales (TTM) -- 8.14 10.07
Price to Book (MRQ) -- 3.76 4.41
Price to Tangible Book (MRQ) -- 4.06 5.24
Price to Cash Flow (TTM) -- 23.02 25.48
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.84 1.66
Dividend Yield - 5 Year Avg -- 1.47 1.34
Dividend 5 Year Growth Rate -- 6.31 6.45
Payout Ratio(TTM) -- 40.95 36.46

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 13.63 15.52
Sales (TTM) vs TTM 1 Yr. Ago -- 6.60 8.73
Sales - 5 Yr. Growth Rate -- 9.20 10.42
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 18.33 19.01
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 5.51 7.17
Capital Spending - 5 Yr. Growth Rate -- 6.92 7.98

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.46 2.46
Current Ratio (MRQ) -- 3.44 3.41
LT Debt to Equity (MRQ) -- 13.40 14.32
Total Debt to Equity (MRQ) -- 18.65 20.12
Interest Coverage (TTM) -- 7.71 15.85

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 51.48 50.11
Gross Margin - 5 Yr. Avg. -- 50.46 51.30
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 17.40 16.09
Operating Margin (TTM) -- -3.15 -8.14
Operating Margin - 5 Yr. Avg. -- 13.64 11.31
Pre-Tax Margin (TTM) -- -3.67 -8.62
Pre-Tax Margin - 5 Yr. Avg. -- 19.70 16.08
Net Profit Margin (TTM) -- -7.34 -12.41
Net Profit Margin - 5 Yr. Avg. -- 14.80 11.25
Effective Tax Rate (TTM) -- 19.59 20.09
Effective Tax Rate - 5 Yr. Avg. -- 22.68 24.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 906,806,787 762,746,808
Net Income/Employee (TTM) -- 106,077,786 89,285,922
Receivable Turnover (TTM) -- 5.52 5.81
Inventory Turnover (TTM) -- 2.55 3.71
Asset Turnover (TTM) -- 0.84 0.81

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 9.96 9.60
Return on Assets - 5 Yr. Avg. -- 11.09 10.56
Return on Investment (TTM) -- 12.41 12.05
Return on Investment - 5 Yr. Avg. -- 14.12 13.45
Return on Equity (TTM) -- 13.73 16.96
Return on Equity - 5 Yr. Avg. -- 15.40 15.00
Note: Units in Millions of US Dollars

Performance for Acasti Pharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.